Radient Pharmaceuticals (RPC) Down 8% After Response to J&J Cancer Test
Go back to Radient Pharmaceuticals (RPC) Down 8% After Response to J&J Cancer Test| Johnson & Johnson (NYSE: JNJ) | Delayed: 266.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $266.35 | 52 Week High | $126.07 | |||
| Open | $266.35 | 52 Week Low | $94.28 | |||
| Day High | $266.35 | P/E | 55.37 | |||
| Day Low | $266.35 | EPS | $4.81 | |||
| Volume | 3,671 | |||||
| Radient Pharmaceuticals (NYSE: RPC) | Delayed: 7.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.90 | 52 Week High | $1.69 | |||
| Open | $7.90 | 52 Week Low | $0.14 | |||
| Day High | $7.90 | P/E | N/A | |||
| Day Low | $7.90 | EPS | $-3.02 | |||
| Volume | 1 | |||||
